Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOLUTEGRAVIR Cause Transient ischaemic attack? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Transient ischaemic attack have been filed in association with DOLUTEGRAVIR (Juluca). This represents 0.1% of all adverse event reports for DOLUTEGRAVIR.

6
Reports of Transient ischaemic attack with DOLUTEGRAVIR
0.1%
of all DOLUTEGRAVIR reports
0
Deaths
1
Hospitalizations

How Dangerous Is Transient ischaemic attack From DOLUTEGRAVIR?

Of the 6 reports, 1 (16.7%) required hospitalization.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOLUTEGRAVIR. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does DOLUTEGRAVIR Cause?

Foetal exposure during pregnancy (1,036) Exposure during pregnancy (776) Virologic failure (770) Pathogen resistance (586) Maternal exposure during pregnancy (517) Viral mutation identified (510) Treatment failure (453) Drug ineffective (447) Off label use (413) Blood hiv rna increased (410)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454)

Which DOLUTEGRAVIR Alternatives Have Lower Transient ischaemic attack Risk?

DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE DOLUTEGRAVIR vs DOLUTEGRAVIR\LAMIVUDINE\TENOFOVIR DISOPROXIL DOLUTEGRAVIR vs DOLUTEGRAVIR\RILPIVIRINE DOLUTEGRAVIR vs DOMPERIDONE DOLUTEGRAVIR vs DOMPERIDONE\PANTOPRAZOLE

Related Pages

DOLUTEGRAVIR Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack DOLUTEGRAVIR Demographics